Assembly Biosciences, Inc. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Assembly Biosciences, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2015-09-30 was 27.28K shares, a 94.74% decline year-over-year.
- Assembly Biosciences, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2015-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2015-03-31 was 266.67K shares.
- Assembly Biosciences, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2014-12-31 was 18.00K shares.
- Assembly Biosciences, Inc. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2014 was 590.40K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2015-09-30 | 27.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 311.94K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 803.26K shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | 266.67K shares 10-Q · filed 2015-05-08 | 1.13M shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | 18.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 590.40K shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 518.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | |
| 2014-06-30 | 322.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | |
| 2014-03-31 | -269.00K shares 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |